Page 1634 - Saunders Comprehensive Review For NCLEX-RN
P. 1634

XV. Second-Line Medications for Tuberculosis (see Box 51-7)
                                A. Rifabutin
                                             1. Description
                                                             a. Inhibits mycobacterial DNA-dependent
                                                                RNA polymerase and suppresses
                                                                protein synthesis
                                                             b. Used to prevent disseminated
                                                                Mycobacterium avium complex (MAC)
                                                                disease in clients with advanced HIV
                                                                infection
                                                             c. Used to treat active MAC disease and
                                                                tuberculosis in clients with HIV
                                                                infection
                                             2. Cautions
                                                             a. Can affect blood levels of some
                                                                medications, including oral
                                                                contraceptives and some medications
                                                                used to treat HIV infection
                                                             b. A nonhormonal method of birth control
                                                                should be used instead of an oral
                                                                contraceptive.
                                             3. Side and adverse effects
                                                             a. Rash
                                                             b. Gastrointestinal disturbances
                                                             c. Neutropenia
                                                             d. Red-orange–colored body secretions

                                                             e.        Uveitis

                                                             f. Myositis

                                                             g.        Arthralgia



                                                             h.        Hepatitis

                                                             i. Chest pain with dyspnea
                                                             j. Flu-like syndrome

                                             4.        Interventions

                                                             a. Observe for hepatotoxic effects; if they
                                                                occur, withhold the medication and
                                                                notify the PHCP.
                                                             b. Assess for painful or swollen joints.
                                                             c. Assess for ocular pain or blurred vision.
                                             5.        Client education: That the medication can be


                                                taken without regard to food
                                B. Rifapentine




                                                         1634
   1629   1630   1631   1632   1633   1634   1635   1636   1637   1638   1639